Lilly plans IPO for Elanco animal-health unit
The Indianapolis-based pharmaceutical company said the division’s headquarters would remain in Greenfield after the spinoff and that no job cuts are planned.
Life Science & Biotech
Articles
Trump health chief Azar renews call to end key drug-pricing tactic
U.S. Health and Human Services Secretary Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.
Biodiversity champion wins Indianapolis Prize for conservation work
The seventh recipient of the prize has been credited with protecting hundreds of species and millions of acres of critical habitat around the world. He will receive $250,000.
Trump health secretary: Drugmakers must help cut prices, or else
Alex Azar, secretary of Health and Human Services and a former executive of Eli Lilly and Co., said Monday that the Trump administration plans to turn up the heat on uncooperative pharma firms.
UPDATE: Eli Lilly buying immuno-oncology company for $1.6 billion
The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.
16 Tech district could help slow Indiana’s brain drain, panel says
The work-play-live district for innovation and entrepreneurship being developed on the near-northwest side will include research labs, apartments and bicycle trails—which could help to attract young workers.
DowDuPont targets deals to sharpen focus at planned spinoffs
DowDuPont Inc. is working on a series of deals to tighten the focus at two of the three spinoffs it plans for next year, including the Corteva Agriscience spinoff, which includes the Indianapolis operations of the former Dow AgroSciences unit.
Indiana life sciences firms raise record $111M in venture capital in 2017
A $44 million VC infusion in 2017 for biosciences firm On Target Laboratories was one indication that Indiana’s life sciences sector is finally starting to pull down some serious venture funding.
UPDATE: 16 Tech district unveils plan for first 4 buildings, lands $38M grant
The 30-acre first phase of the 16 Tech innovation district, long touted as an up-and-coming hub for entrepreneurship and innovation, will be spurred by a $120 million investment from Browning and a $38 million grant from Lilly Endowment.
Biotech firm plans expansion in Franklin, 23 new jobs
Its $1.5 million investment is expected to help B2S Life Sciences more than double its staff and grow its client base, which includes contract research groups, pharmaceutical firms and biotech startups.
DowDuPont unveils name for ag division: Corteva AgriScience
The agricultural spinoff includes the Indianapolis operations of the former Dow AgroSciences headquarters, which employs about 1,500.
IU Med School raises $135M in NIH funding for 2017, setting record
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.
Two Hoosier companies pull off IPOs
OrthoPediatrics Corp. raised $52 million on Oct. 12, and Carmel-based Merchants Bancorp raised $115 million on Oct. 27.
IU Health expands specialty cancer program into new facility
The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
Bill to end government shutdown delays medical device tax for two years
The bill that President Donald Trump signed Monday night to reopen the federal government included a two-year delay in implementing a tax on medical devices, bringing praise from Indiana-based Cook Group.
Two Indiana agricultural associations complete merger
The Agribusiness Council of Indiana has merged with the Indiana Seed Trade Association, the associations announced Wednesday.
Local agricultural giant JBS United changing its name
One of the Indianapolis-area’s largest private companies is taking on a different name to better reflect its mission in livestock health.
Tax on medical devices to resume after two-year suspension
The 2.3 percent federal excise tax on medical device manufacturers originally imposed in 2013 as one of several taxes and fees in the Affordable Care Act
Assembly Biosciences’ market value surges to nearly $1B, despite red ink
The 5-year-old Carmel biotech has won plenty of attention from Wall Street and has secured more than $100 million through licensing deals and a stock offering to help fund expensive clinical trials.
Fishers medical manufacturer with 69 employees plans closure
Hill-Rom Holdings Inc., which owns Tridien Medical, said it plans to begin eliminating employees Jan. 31 with terminations continuing until Sept. 30, when the facility will permanently close.